Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407744 · ClinicalTrials.gov registry record
Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial
A clinical trial of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT01407744: Completed study of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma, sponsored by Children's Oncology Group.
NCT01407744 is a study of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma that has completed, run by Children's Oncology Group. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01407744, a study of Childhood Infratentorial Ependymoma and Childhood Supratentorial Ependymoma, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial studies tumor samples from patients with ependymoma treated on the Children Oncology Group ACNS0121 trial. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer.
Primary Outcome
The multivariable Cox model and cumulative incidence regression models will be used. Associations between the biology markers and outcome variables will be studied in a single-variable setting as well as via multivariable Cox models.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (1)
California
- Children's Oncology Group - Monrovia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-04 |
What the finished NCT01407744 record still lists
NCT01407744 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 3 conditions, with Childhood Infratentorial Ependymoma appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01407744 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01407744 about?
NCT01407744 is a clinical study titled "Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial". This research trial studies tumor samples from patients with ependymoma treated on the Children Oncology Group ACNS0121 trial. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to c...
What is the current status of trial NCT01407744?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2012-03. Estimated completion is 2013-04.
What conditions does trial NCT01407744 study?
This clinical trial studies the following conditions: Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma.
What interventions are being tested in trial NCT01407744?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01407744?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01407744 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Infratentorial Ependymoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia